(University of Florida) The addition of a small molecule to the cancer drug Temozolomide disrupts repair mechanisms in a type of tumor cells that is highly resistant to treatment.
Small addition to cancer drug may make big differenceCourtesy EurekAlert! - Cancer Mon, 12/07/2009 - 23:00
(University of Florida) The addition of a small molecule to the cancer drug Temozolomide disrupts repair mechanisms in a type of tumor cells that is highly resistant to treatment. More related itemsDementia plaque 'rapidly cleared'
Rare Benign Tumor Responds to Cancer Drug
FDA approves Roche skin cancer drug Erivedge
|
Popular by tags WeekMonth |
Post new comment